15 July 2016

From the Milky Way to the Solar System: Wnt's the Matter?

Organised by:

 SCI's Biotechnology Group in partnership with the University of Westminster

University of Westminster

Registration Closed

This event is no longer available for registration.

Prostate cancer is the most common cancer in men. Convential therapies target androgen signalling, however, they provide limited survival benefits for patients. The Wnt signalling pathway induces expression of target genes through cell surface receptors. It was found that prostate cancer cell lines express high levels of Wnt-11, a non canonical member of the Wnt family.

Day 1 - 15 July 2016

Event Schedule
Event begins
Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

University of Westminster

School of Life Sciences
115 New Cavendish Street
London W1W 6UW

SCI Communications Team

Tel: +44 (0) 20 7598 1594

Email: communications@soci.org

This is a free event, no need to book. Please check this page for any updates or changes before attending the event.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Additional Info


Dr Pinar Onganer, Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster